Biotech

All Articles

Praxis epilepsy medication minimizes seizures in period 2 trial

.Practice Preciseness Medicines has scored an additional midphase win in epilepsy this year, with it...

Three officers resign as Dyne blog posts blended information for DMD applicant

.After getting away a medical grip several years back, Dyne Therapy has actually revealed brand new ...

Arrowhead fires off period 3 information in rare metabolic ailment in front of market encounter Ionis

.Arrowhead Pharmaceuticals has presented its own give ahead of a possible showdown along with Ionis,...

Pfizer, Valneva show lyme illness chance reliable for 2nd enhancer

.Pfizer and Valneva might possess concerning pair of even more years to stand by just before they pr...

Fierce Biotech Editor-in-Chief Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Let's study a discussion with Ayla Ellison, Ferocious Biotech Editor-in-Chief and Michelle Benz as ...

New information demonstrate how Bayer's asundexian fell short to stop movements

.Bayer suspended the phase 3 trial for its own factor XIa inhibitor asundexian behind time last year...

Sanofi's tolebrutinib stops working 2 of 3 late-stage MS trials

.Sanofi is actually still bented on taking its several sclerosis (MS) med tolebrutinib to the FDA, e...

Galapagos' stockpile as fund reveals intent to shape its own progression

.Galapagos is actually coming under added tension from real estate investors. Having actually create...

Cell- concentrated Sana gathers initial CSO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of significant leadership hirings, firings a...

Allist pays Jacobio $21M, landing job in Chinese KRAS race

.Shanghai Allist Pharmaceuticals has actually acquired itself a starring role in China's KRAS market...